DUSP1-mediated suppression of p38 MAPK signaling pathway reduces ferroptosis in cerebral ischemia-reperfusion injury

  • 0Department of Neurology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

|

|

Summary

This summary is machine-generated.

Dual specificity phosphatase 1 (DUSP1) protects against brain injury after stroke by regulating ferroptosis. DUSP1 overexpression reduces ferroptosis and brain damage, while its inhibition worsens outcomes.

Area Of Science

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background

  • Ferroptosis is a key factor in cerebral ischemia-reperfusion injury (CI/RI), impacting neurological function.
  • Dual specificity phosphatase 1 (DUSP1) shows neuroprotective potential, but its role in ferroptosis is unclear.

Purpose Of The Study

  • To investigate DUSP1's therapeutic potential by examining its role in ferroptosis modulation in cerebral ischemia-reperfusion injury.
  • To elucidate the mechanism of DUSP1's neuroprotection via ferroptosis regulation.

Main Methods

  • In vitro: PC12 cells subjected to oxygen-glucose deprivation/reoxygenation (OGD/R) with DUSP1 manipulation (overexpression/knockdown).
  • In vivo: Middle cerebral artery occlusion/reperfusion (MCAO/R) rat models with DUSP1 pharmacological inhibition.
  • Assessed ferroptosis markers, cell viability, infarction volume, neurological deficits, and histopathology.
  • Investigated the involvement of the p38 mitogen-activated protein kinase pathway.

Main Results

  • Ferroptosis was induced in OGD/R and MCAO/R models, correlating with increased DUSP1 expression.
  • DUSP1 overexpression attenuated ferroptosis and CI/RI, while knockdown worsened injury.
  • DUSP1 inhibition aggravated cerebral injury and ferroptosis markers in MCAO/R rats.
  • Adezipimod treatment rescued ferroptosis in DUSP1-deficient cells by modulating key ferroptosis-related proteins.

Conclusions

  • DUSP1 confers neuroprotection against CI/RI by regulating ferroptosis via the p38 pathway.
  • DUSP1 represents a promising therapeutic target for ischemic stroke treatment.